Background:Induction of labour is the process of initiating the labour by artificial means from 24 weeks of gestation. The main aim of this study is to find out the maternal and foetal outcomes after induction of labour with misoprostol and oxytocin beyond 37 weeks of gestation.Methods:This was a hospital-based observational study carried out at Paropakar Maternity and Women’s Hospital, Nepal. Misoprostol of 25 µg was inserted in posterior fornix of vagina or oxytocin infusion was started from 2.5 units on whom induction was decided. Maternal and foetal/neonatal outcomes were observed. Collected data were analysed using SPSS and MS Excel.Results:General induction rate was found to be 7.2%. In this study, post-term pregnancy was found to be the most common reason for induction of labour. Analysis of onset of labour led to the finding that mean onset of labour was much rapid in oxytocin (6.6 h) than misoprostol (13.6 h). However, there is similarity in induction–delivery interval in both groups. Overall, the rate of normal delivery and caesarean section was found to be 64.9% and 33.2%, respectively. Similarly, normal delivery within 12 h was seen in 18.4% of the patients given with misoprostol and 43.5% in oxytocin group. Foetal distress was found as the most common reason for caesarean section. The overall occurrence of maternal complication was found to be similar in misoprostol and oxytocin groups, nausea/vomiting being the most common (36.7%) complication followed by fever (24.1%). Besides this, the most common neonatal complication found in overall cases was meconium stained liquor (49.2%).Conclusion:It was found that misoprostol was used most frequently for induction of labour compared to oxytocin. The onset of labour was found to be rapid in oxytocin than misoprostol. However, the occurrence of side effects was found to be similar in both misoprostol and oxytocin groups.
Background & Objectives:Prevention of Mother to child Transmission (PMTCT) is a global intervention which aims at preventing mother to child transmission of Human Immunodeficiency Virus (HIV). The study aims to find out knowledge of pregnant women on Mother to child Transmission (MTCT) of HIV/AIDS (Acquired Immune Deficiency Syndrome).Materials & Methods:A cross-sectional study was carried out at Paropakar Maternity and Women’s Hospital, Kathmandu, Nepal among the pregnant women who came to visit Antenatal Clinic. Data was collected using non-probability purposive sampling technique. Face to face interview was done and a structured questionnaire was developed for data collection. Data analysis and interpretation were done in SPSS and MS Excel.Results:The total number of respondents was 80 with a mean age of 27.4 years. 90% (n=72) respondents were found to be literate. 86.3% (n=69) were well aware of the knowledge on PMTCT. Majority of the respondents (40%) mentioned that radio, TV/Media were the main sources of information about HIV/AIDS. Out of 32.5% (26) who had heard about the window period, only 26.9% (n=7) gave the correct answer. 93.8% (n=75) were well known about the routes of transmission of HIV but only 10.1% (n=7) gave the correct answer about it. Further, 54% (n=43) respondents knew about the availability of drugs to reduce MTCT of HIV/AIDS.Conclusion:The level of awareness about PMTCT among antenatal mothers was satisfactory. However, knowledge was inadequate which imparts for the need of health education about MTCT of HIV/AIDS in every health facilities of Nepal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.